Dr. Stephanie A Fitzwilliam Psychologist - Clinical Medicare: Medicare Enrolled Practice Location: Cond. El Bosque, Apt.1203, Guaynabo, PR 00971 Phone: 787-593-8380 Fax: 787-720-9464 |
Wanda M. Figueroa Psychologist - Counseling Medicare: Not Enrolled in Medicare Practice Location: Cond Chalets Del Parque Apt 4b-3, Guaynabo, PR 00969 Phone: 787-487-4254 |
Dr. Aidyl J. Lozada, PH.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: Corporate Office Park, Asg Building Suite 301, Guaynabo, PR 00966 Phone: 787-800-9294 |
Ms. Carmen J. Cortes, M.S. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 2118 Calle Turquesa, Alto Apolo, Guaynabo, PR 00969 Phone: 787-413-4891 |
Gabriel Emilio Cabrera, PSY D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 2100 Calle Turquesa Bucare, Suite 105, Guaynabo, PR 00969 Phone: 787-404-5933 |
Dr. Carol Y Irizarry-robles, PHD Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 36 Carr 20 Ste 301, Guaynabo, PR 00966 Phone: 787-800-9294 |
Giovanni Martinez-mujica Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2100 Calle Turquesa, Suite 105, Guaynabo, PR 00969 Phone: 787-404-5318 |
Dr. Luis Antonio Rivas, PH.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: G32 Calle La Santa, Colinas Metropolitanas, Guaynabo, PR 00969 Phone: 787-461-2604 |
Ms. Alma Y. Varela Dieppa, MA Psychologist Medicare: Not Enrolled in Medicare Practice Location: 12-6 Calle Segovia, Urbanizacion Torrimar, Guaynabo, PR 00966 Phone: 787-783-3154 Fax: 787-273-9861 |
News Archive
Low dairy consumption is common among low- and middle-income countries (LMICs); however, with the demand for milk in these countries projected to increase over the next few decades, there is an opportunity to improve the lives of millions of people from the nutritional benefits of dairy products.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that it is initiating a Phase 2 clinical study of STA-9090 in patients with advanced gastrointestinal stromal tumors (GIST). This is the sixth clinical study of STA-9090, a potent, synthetic, small molecule Hsp90 inhibitor with a novel chemical structure.
For years, it was believed that obese women were at lower risk for developing osteoporosis, and that excess body fat actually protected against bone loss. However, a study presented today at the annual meeting of the Radiological Society of North America (RSNA) found that having too much internal abdominal fat may, in fact, have a damaging effect on bone health.
Researchers at the University at Buffalo have identified two components of saliva that may serve as the basis for novel tests to determine the risk for future loss of the bone that holds teeth in place.
› Verified 5 days ago